Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3451]

NICE rejects use of abiraterone for advanced prostate cancer before chemo

NICE rejects use of abiraterone for advanced prostate cancer before chemo

Lymph node ultrasounds more accurate in obese breast cancer patients, Mayo Clinic study finds

Lymph node ultrasounds more accurate in obese breast cancer patients, Mayo Clinic study finds

Poor quality of life doesn’t predict low survival rates in high-risk lung cancer patients undergoing surgery

Poor quality of life doesn’t predict low survival rates in high-risk lung cancer patients undergoing surgery

Half of all UK cancer patients now survive at least 10 years

Half of all UK cancer patients now survive at least 10 years

Receiving chemotherapy after a breast cancer diagnosis may affect a patient’s long-term employment

Receiving chemotherapy after a breast cancer diagnosis may affect a patient’s long-term employment

Where cancer news goes wrong: Bridging the communication gap

Where cancer news goes wrong: Bridging the communication gap

EMA alerts EU healthcare professionals after vials of falsified Herceptin identified

EMA alerts EU healthcare professionals after vials of falsified Herceptin identified

UK NICE guidance recommends degarelix for the treatment of advanced hormone-dependent prostate cancer only in people with impending spinal cord compression

UK NICE guidance recommends degarelix for the treatment of advanced hormone-dependent prostate cancer only in...

Chemotherapy before or after surgery for high-risk bladder cancer improves survival but is not routinely administered

Chemotherapy before or after surgery for high-risk bladder cancer improves survival but is not routinely...

Challenges to effective cancer control in China, India, and Russia

Challenges to effective cancer control in China, India, and Russia

More from ecancer